The biotransformation of the fungal protein synthesis inhibitor sordarin is
reported. Nine taxonomically diverse organisms supported the isolation and
identification of twelve modified products, The structural diversity of th
e biotransformation products observed and their value in supporting further
chemistry is discussed.